Ribomic Inc. (TSE: 4591)
Health Care · Biotechnology · JP
¥68.00
-4.23% today · -26.1% 1Y
Ribomic Inc. (TSE: 4591) operates in the Biotechnology industry within the Health Care sector. The company is valued at $24.36M and employs 25 people.
Over the last twelve months the share price has lost 26.1%, trading between 57.00 and 120.00.
Tweenvest scores Ribomic Inc. across four factors: quality 39/100, value 41/100. Its strongest factor is value.
4591 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $24.36M
- Revenue (TTM)
- $46.14K
- P/E
- —
- EPS
- -22.69
- Dividend yield
- —
- Beta (5Y)
- 0.27
- 52-week high
- ¥120.00
- 52-week low
- ¥57.00
- Avg volume (3M)
- —
- Shares outstanding
- 56.55M
- Employees
- 25
- Next earnings
- —
About Ribomic Inc.
Ribomic Inc. is a Japanese biopharmaceutical company dedicated to identifying and advancing medicinal compounds. The firm employs RNA aptamers in its drug development efforts, targeting various significant health issues such as wet age-related macular degeneration, achondroplasia, pulmonary arterial hypertension, proliferative vitreoretinopathy, heart failure, osteoarthritis, and asthma. Furthermore, Ribomic manufactures specialized separating agents used for the affinity purification of human IgG and Fc-fusion proteins. Established in 2003, the company's main operations are based in Tokyo, Japan.
- ISIN
- JP3974850004
- Founded
- 2003
- Listed since
- Sep 25, 2014
- Exchange
- The Tokyo Stock Exchange
- Currency
- JPY
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Thiogenesis Therapeutics, Corp.TSXV: TTI | $24.74M | CA$0.50 | -5.66% |
| Seres Therapeutics, Inc.NasdaqGS: MCRB | $24.71M | $2.46 | -9.23% |
| Lukas Biomedical Inc.TPEX: 6814 | $24.52M | NT$19.00 | +2.70% |
| Original BioMedicals Co., Ltd.TPEX: 6483 | $24.50M | NT$11.90 | +3.93% |
| Polyrizon Ltd.NasdaqCM: PLRZ | $24.29M | $10.00 | +11.26% |
| Shuttle Pharmaceuticals Holdings, Inc.NasdaqCM: SHPH | $24.20M | $5.08 | -4.69% |
| Eutilex.Co.,LtdKOSDAQ: A263050 | $24.14M | ₩— | — |
| ABVC BioPharma, Inc.NasdaqCM: ABVC | $23.80M | $0.92 | -8.21% |
Figures last refreshed Oct 18, 2026.